ARCHIMED

With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €8 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.

Site web

http://www.archimed.group

Lien externe pour ARCHIMED

Secteur

Directeurs du capital-risque et du capital-investissement

Taille de l’entreprise

51-200 employés

Siège social

Lyon, Auvergne-Rhone-Alpes

Type

Société civile/Société commerciale/Autres types de sociétés

Fondée en

2014

Domaines

Diagnostics, Consumer Health, Pharma Services, Biopharma Products, MedTech, Healthcare IT, Life Science Tools et Biologic Services